| 1 |
35124000 | Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4/ROS/VEGF pathway. | 2022 Apr 1 |
1 |
| 2 |
30416384 | GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction. | 2018 |
2 |
| 3 |
28808291 | GLP-1 Inhibits High-Glucose-Induced Oxidative Injury of Vascular Endothelial Cells. | 2017 Aug 14 |
1 |
| 4 |
26679229 | Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis. | 2016 Jan 26 |
2 |
| 5 |
25384196 | Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension. | 2015 May |
1 |
| 6 |
25980358 | Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. | 2015 Sep |
2 |
| 7 |
26632709 | Protective Role of Glucagon-Like Peptide-1 Against High-Glucose-Induced Endothelial Oxidative Damage. | 2015 Nov |
3 |
| 8 |
23806684 | LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. | 2013 Jul 19 |
2 |
| 9 |
21388644 | Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level. | 2011 Sep |
1 |
| 10 |
20026306 | Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression. | 2010 Jan 15 |
1 |